- Home
- PFSI vs BIO Comparison
PFSI vs BIO Comparison
Compare PFSI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFSI
- BIO
- Stock Information
- Founded
- PFSI 2008
- BIO 1952
- Country
- PFSI United States
- BIO United States
- Employees
- PFSI N/A
- BIO N/A
- Industry
- PFSI Finance: Consumer Services
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- PFSI Finance
- BIO Industrials
- Exchange
- PFSI Nasdaq
- BIO Nasdaq
- Market Cap
- PFSI 5.3B
- BIO 6.0B
- IPO Year
- PFSI 2013
- BIO N/A
- Fundamental
- Price
- PFSI $98.60
- BIO $247.21
- Analyst Decision
- PFSI Buy
- BIO Strong Buy
- Analyst Count
- PFSI 7
- BIO 4
- Target Price
- PFSI $122.14
- BIO $324.25
- AVG Volume (30 Days)
- PFSI 395.6K
- BIO 374.0K
- Earning Date
- PFSI 07-22-2025
- BIO 07-31-2025
- Dividend Yield
- PFSI 1.21%
- BIO N/A
- EPS Growth
- PFSI 123.72
- BIO N/A
- EPS
- PFSI 6.51
- BIO N/A
- Revenue
- PFSI $3,386,736,000.00
- BIO $2,541,100,000.00
- Revenue This Year
- PFSI N/A
- BIO N/A
- Revenue Next Year
- PFSI $17.64
- BIO $3.42
- P/E Ratio
- PFSI $15.19
- BIO N/A
- Revenue Growth
- PFSI 66.25
- BIO N/A
- 52 Week Low
- PFSI $85.74
- BIO $211.43
- 52 Week High
- PFSI $119.13
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- PFSI 48.58
- BIO 53.59
- Support Level
- PFSI $100.06
- BIO $245.87
- Resistance Level
- PFSI $101.01
- BIO $264.68
- Average True Range (ATR)
- PFSI 2.11
- BIO 7.33
- MACD
- PFSI -0.09
- BIO 0.49
- Stochastic Oscillator
- PFSI 23.21
- BIO 41.12
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.